SCHEMBL2920574

SCHEMBL2920574

C[Si](C)(C)OC(CCl)C(N)Cc1ccccc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 2/20 0.43
TAAR1 Q96RJ0 2/20 0.43
MAOA P21397 1/20 0.43
SLC6A4 P31645 1/20 0.43
SLC6A3 Q01959 1/20 0.43
SIGMAR1 Q99720 1/20 0.43
CYP2A6 P11509 1/20 0.43
ADORA2A P29274 1/20 0.43
ADORA1 P30542 1/20 0.43
EPHX1 P07099 1/20 0.41
ANPEP P15144 2/20 0.41
LAP3 P28838 2/20 0.41
CYP2D6 P10635 1/20 0.41
CSNK1E P49674 1/20 0.38
ALPI P09923 1/20 0.36
PKM P14618 1/20 0.36
PTGS1 P23219 1/20 0.36
XIAP P98170 1/20 0.36
SLC7A5 Q01650 1/20 0.36
TRPA1 O75762 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2921987 0.75 EPHX1 (0.50) SLC6A2TAAR1MAOASLC6A4SLC6A3
SCHEMBL3032994 0.74 SLC15A1 (0.45) SLC6A2TAAR1MAOASLC6A4SLC6A3
SCHEMBL5596806 0.70 CYP2D6 (0.68) SLC6A2TAAR1MAOASLC6A4SLC6A3
SCHEMBL24017042 0.70 EPHX1 (0.70) SLC6A2TAAR1MAOASLC6A4SLC6A3
SCHEMBL9536448 0.70 EPHX1 (0.70) SLC6A2TAAR1MAOASLC6A4SLC6A3
SCHEMBL9621395 0.68 TRPA1 (0.44) SLC6A2TAAR1MAOASLC6A4SLC6A3
SCHEMBL14671509 0.68 EPHX1 (0.56) SLC6A2TAAR1MAOASLC6A4SLC6A3
SCHEMBL14541149 0.68 EPHX1 (0.56) SLC6A2TAAR1MAOASLC6A4SLC6A3
SCHEMBL5170196 0.68 EPHX1 (0.56) SLC6A2TAAR1MAOASLC6A4SLC6A3
SCHEMBL7983260 0.68 EPHX1 (0.56) SLC6A2TAAR1MAOASLC6A4SLC6A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1784407-B1 2-ARYLMETHYLAZETIDINE CARBAPENEM DERIVATIVES AND PREPARATION THEREOF KOREA RES INST CHEM TECH (KR) 2010-09-08 EP disclosed
US-7662810-B2 Potassium(1R,5S,6S)-2-(1-benzyl-azetidine-3-yl-thio)-6-[(1R)-1-hydroxyethyl]-1-methylcarbapen-2-em-3-carboxylate; antibacterial activities against Grampositive and Gramnegative bacteria and excellent antibacterial activities against resistant bacteria such as methicillin resistant Staphylococcus aureus KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 2010-02-16 US disclosed
US-20070244089-A1 2- Arylmethylazetidine Carbapenem Derivatives and Preparation Thereof KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 2007-10-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070244089-A1 2- Arylmethylazetidine Carbapenem Derivatives and Preparation Thereof SCN9A, SCN2A, SCN5A SLC6A2 2382/4885TAAR1 4791/4885MAOA 843/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.